FEATURED INDUSTRY EXPERTS
Medical Affairs Council Chair
Mary Alice Dwyer
Former VP, Global Medical Excellence
and Patient Centricity
Mary Alice is currently Principle/Consultant with Medical Innovations and Insights, LLC providing Medical Affairs consulting services for organizations seeking to develop best-in-class Medical Affairs teams and patient-centric practices.
VP Head of Medical Capabilities, Oncology
Andrew is a results-oriented scientific leader with over 15 years of experience leading Medical Affairs teams through product launches, developing medical strategy, fostering strong KOL relationships, and bridging and clinical research and scientific expertise with business acumen.
Head of Global Medical Information and Operations, GSK
Andy is an experienced leader with strong tracking record building and leading a variety of high performing R&D and Medical teams at a country, regional and global level as well as delivering enterprise-wide transformation initiatives.
Executive Director, Global Medical Resources AstraZeneca
Bill has extensive experience in Medical Affairs including both US and Global responsibilities. Bill’s areas of expertise include leadership of teams including cross functional and Global, IT platform development and implementation, MSL and MI capabilities, Innovation and Simplification.
Christiane Nina Belly
Global Medical Affairs Lead Digital Transformation, MSD
Blending her clinical practice experience as board-certified anesthesiologist with over 20 years as pharmaceutical executive in commercial and medical leadership roles she masters both strategy development as well as operational excellence in matrixed environments up to the Global levels
David Tang, PharmD
Vice-President, Global Medical Affairs & Strategic Planning, Allergan
David leads the Global Medical Affairs and Chief Medical Office Strategic Planning organization comprised of the worldwide therapeutic area Medical Affairs, US MSL, post-approval trial management, publications and medical education teams.
Deb Long, MD
Vice President Medical Affairs
Deborah held various leadership roles in medical affairs, including leading the US Medical Affairs COPD team at GSK, and the Americas Internal Medicine Medical Monitoring group at PRA. Deborah spent a decade practicing pulmonary and critical care medicine prior to joining the pharmaceutical industry.
Dominick Albano, PharmD, MBA
VP, Global Medical Information
Dominick, one of the founding members of phactMI (Pharma Collaboration for Transparent Medical Information), has spent most of his industry career working in Medical Information and Medical Affairs. He developed the “Theory of MI Relativity”, which describes the importance of awareness, trust/quality, and access as critical factors in MI utility.
Donna Booth, PharmD
Sr. Director, Strategic Initiatives Lead, Value, Evidence and Outcome, GSK
Donna is an experienced Medical Affairs professional with expertise in building and leading effective teams across Medical Affairs. Her focus has been on leading high performing Medical Information teams aligned to a variety of therapeutic areas as well as teams aligned to National/Regional payers, Integrated Delivery Networks and Policymakers.
Dr Michael Elliott, FRCP, MBA, PharmD
Vice President, Medical Affairs, Europe, Middle East & Australasia, Gilead Sciences
Mike has extensive experience in the pharmaceutical industry. Over the past twenty years, Mike has led global development programs of early and late stage compounds and has been involved in medicine development, clinical research as well as medical affairs.
Global Medical Digital, Strategy and Capabilities, Eli Lilly and Past President, phactMI
Jennifer led the Lilly Medical Affairs digital transformation by creating the medical digital strategy, enabling delivery of an award-winning global web platform and customer experience, and establishing and implementing the medical affairs social media strategy.
Head Med Info & Communication, Novartis
As Head of PLS US Medical at Novartis, Joanne is responsible for leading a cross divisional department that supports all therapeutic areas of Novartis in the areas of Medical Information and Communication, Content Development and MSL Capability Training and Medical Compliance training.
Maureen Feeney, PharmD, MBA
VP Scientific Communications, US Medical Office, Takeda
Maureen develops the strategic processes behind the development of global scientific communication for the full portfolio of Takeda pipeline and marketed products addressing unmet medical needs in respective treatment areas. She oversees the development and implementation of compliant, fit-for-purpose medical communication platforms and associated content for Takeda assets and disease areas.
Meg Heim, MBA
Vice President, Head of North America Diabetes and Cardiovascular Scientific Communications,
Meg has reputation for successful partnerships with Corporate, Pharm and BioTech, Government, Advocacy and Academic groups to create consensus and build programs that create healthcare transformative change. She is a strategic thinker who is adept at resolving complex issues.
Michael Kavanaugh, BS, MBA
Executive Director, Clinical Development and Medical Affairs Effectiveness and Scientific Communications, Boehringer Ingelheim
Seasoned pharmaceutical executive with experience in Marketing, Sales Operations, Marketing Operations, Medical Affairs and Clinical Development. A change agent and leader with proven skills in agility and problem solving. In his current role Mike oversees the Publications, Medical Education, External Research, Medical Information, Medical/Customer Call Center as well as the Stakeholder Relations team.
Richard Swank, Ph.D
Executive Director and Head, US Medical Capabilities, Amgen
Richard heads US Medical Capabilities at Amgen encompassing medical liaisons across five therapeutic areas, the US Med Info Call Center, REMS, and US Medical Events. He has been at Amgen since 2003 and prior to that worked for Organon-Sanofi Synthelabo.
Robin Winter-Sperry, MD
Global Field Based Medical Excellence Head
Works transversely to contribute to internal working groups for process improvements, strategy and tactics. Leads Global FBM Strategy Development and Ensures clarity and harmonization of roles and responsibilities of the Field Based Medical (FBM)/MSL function across internal and external stakeholders worldwide.
Vice President, Global Medical Communications, Alexion Pharmaceuticals
Medical Communications executive with extensive US and Global experience including strategic planning and building capabilities supporting Global Medical Affairs functions. Sarah has a successful track record of developing and leading high-performing Medical Communications teams in environments of rapid organizational growth